ArticleBMC cancer2021

Nivolumab plus ipilimumab versus nivolumab in individuals with treatment-naive programmed death-ligand 1 positive metastatic soft tissue sarcomas: a multicentre retrospective study.

Yaolin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.